6505--F-18 PSMA Pylarify

The Department of Veterans Affairs, Network Contracting Office 6, has issued a Justification and Approval under solicitation number 36C24625R0016 for the procurement of F-18 Pylarify (piflufolastat or 18F-DCFPyl) radiopharmaceutical. This requirement facilitates the delivery of specialized medical supplies to the Durham VA Medical Center in Durham, North Carolina. The government intends to award an open market Indefinite Delivery Indefinite Quantity (IDIQ) contract to Progenics Pharmaceuticals Inc., which is identified as the sole source for this specific radiopharmaceutical.

The contract is classified under PSC 6505 for drugs and biologicals and NAICS 325412 for pharmaceutical preparation manufacturing. Progenics Pharmaceuticals Inc. qualifies as a small business under the 1,300-employee size standard for this NAICS code. The anticipated period of performance begins with a one-year base period running from January 1, 2025, through December 31, 2025, followed by three one-year option periods.

Point of contact Daniel Spaulding is managing this action, which includes two associated attachments: a contract document and a redacted FAR 13.5 sole source justification. The total estimated value for the base and all option periods is redacted in the formal notice. This acquisition ensures the availability of essential pharmaceutical preparations for veteran healthcare services at the designated North Carolina facility.